The state of Texas, led by Attorney General Ken Paxton, has filed a civil complaint against Dr. Jason Jarin — a pediatric and adolescent gynecologist affiliated with UT Southwestern Medical Center and Children’s Health System of Texas — and the hospital system itself. The suit centers on how certain services were billed to Texas Medicaid and CHIP, and seeks injunctive relief, financial penalties and other remedies tied to allegedly improper claims.
What the complaint alleges
– Paxton’s office claims Dr. Jarin and the health system recorded patients’ genders on insurance claims in ways that allowed coverage of care tied to gender identity. – The filing says some treatments typically associated with gender-affirming care — specifically puberty blockers and cross-sex hormone therapy — were submitted under diagnostic codes normally covered for cisgender patients, such as precocious puberty or irregular menstrual bleeding, instead of codes referencing gender dysphoria or gender-affirming treatment. – The state argues these coding choices were used to avoid denials under Texas laws that restrict certain medical interventions for minors.
Examples and evidence cited
– The complaint identifies unnamed patients and points to discrepancies between the sex assigned at birth and the genders recorded on claims. – It alleges instances like testosterone prescriptions tied to male gender entries for patients the filing says were female at birth, and menstrual-suppression care billed under categories for excessive bleeding for patients listed as female despite being male at birth. – Texas contends such entries misrepresent the clinical context and amount to attempts to secure coverage that would otherwise be denied under state law.
Potential consequences
– If the state’s claims are proven, the case could trigger administrative billing reviews, audits of Medicaid/CHIP claims, civil penalties, demands for repayments, and possible licensing inquiries for clinicians involved. – Beyond legal penalties, hospitals and providers could face reputational damage and operational disruption while the matter is litigated.
Responses from defendants and medical groups
– Children’s Health System of Texas has said it complies with applicable local, state and federal health laws and that patient welfare guides clinical decisions. Dr. Jarin acknowledged receiving the suit but has not otherwise commented publicly. – Major medical organizations — including the American Medical Association, the Endocrine Society and the American Psychological Association — have urged that gender-affirming care remain available when clinically indicated and opposed sweeping bans that remove clinician discretion. Advocates warn that restrictions on evidence-based care risk harming youth and creating unequal treatment.
Why this matters now
– The lawsuit sits at the intersection of medical practice, insurer rules and state oversight. Courts and regulators nationally are increasingly wrestling with whether identical medical interventions should be treated differently depending on whether the patient is transgender or cisgender. – The case could clarify how diagnoses and gender entries should be recorded on claims and how payers interpret those records when deciding coverage. That guidance will affect clinical documentation, prescribing and consent processes, and how health systems train staff on billing and coding.
Legal framing and broader context
– Paxton’s office frames the litigation as a consumer-protection and law-enforcement action, saying billing and documentation misrepresentations exposed taxpayers to improper costs. The complaint is one of multiple actions the attorney general has brought related to care for transgender minors. – Courts will ultimately weigh the factual record around billing practices and assess how state statutes intersect with medical standards, insurance policy and potential constitutional claims.
Practical takeaways for providers
– Health systems should review and clearly document clinical rationale, ensure coding matches medical records, and consult institutional counsel and specialty guidance when deciding on treatment transitions or continuations under current state law. – Professional societies advise clinicians to follow established clinical guidelines and to keep careful records that demonstrate medical necessity and informed consent.
What to watch next
– Expect additional filings, motions and likely court decisions that could set precedents for how pediatric treatment related to gender identity is documented, billed and regulated in Texas and beyond. The outcome will influence enforcement priorities, payer reviews and how health systems reconcile patient care with evolving legal requirements.